Maro Ohanian

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 335 citations · Full text

Hematological Malignancy, Oncology, Biochemistry +8

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch et al. · The Lancet Haematology · 2020 · 325 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia

Jan A. Burger, Mariela Sivina, Nitin Jain et al. · Blood · 2018 · 219 citations · Full text

Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens

Curtis A. Lachowiez, Sanam Loghavi, Tapan M. Kadia et al. · Blood Advances · 2020 · 153 citations · Full text